APA (7th ed.) Citation

de Faria, A. G. A., Chaves, F. C., Ferraz, M. L. G., & Andrade, L. E. C. (2021). Selective decrease in complement C2 hemolytic activity is a sensitive marker for cryoglobulinemia and active disease in hepatitis C patients. Digestive and liver disease, 53(7), 860-865. https://doi.org/10.1016/j.dld.2020.12.124

Chicago Style (17th ed.) Citation

de Faria, Atila Granados Afonso, Fernanda Correa Chaves, Maria Lucia Gomes Ferraz, and Luis Eduardo Coelho Andrade. "Selective Decrease in Complement C2 Hemolytic Activity Is a Sensitive Marker for Cryoglobulinemia and Active Disease in Hepatitis C Patients." Digestive and Liver Disease 53, no. 7 (2021): 860-865. https://doi.org/10.1016/j.dld.2020.12.124.

MLA (9th ed.) Citation

de Faria, Atila Granados Afonso, et al. "Selective Decrease in Complement C2 Hemolytic Activity Is a Sensitive Marker for Cryoglobulinemia and Active Disease in Hepatitis C Patients." Digestive and Liver Disease, vol. 53, no. 7, 2021, pp. 860-865, https://doi.org/10.1016/j.dld.2020.12.124.